Kiaie Namvar 5
5 · Aditx Therapeutics, Inc. · Filed Feb 12, 2021
Insider Transaction Report
Form 5
Kiaie Namvar
Director
Transactions
- Purchase
Common Stock
2020-07-02+1,111→ 2,222 total - Exercise of In-Money
Common Stock
2020-07-22$11.25/sh+1,111$12,499→ 2,222 total - Purchase
Series A Warrant
2020-07-02+1,111→ 1,111 totalExercise: $4.50From: 2020-07-02Exp: 2025-07-02→ Common Stock (1,111 underlying) - Purchase
Series B Warrant
2020-07-02+1,111→ 0 totalExercise: $11.25From: 2020-07-02Exp: 2025-07-02→ Common Stock (1,111 underlying) - Exercise of In-Money
Series B Warrant
2020-07-22$11.25/sh−1,111$12,499→ 0 totalExercise: $0.00From: 2020-07-02Exp: 2025-07-02→ Common Stock (1,111 underlying)
Footnotes (1)
- [F1]The reported securities are included within 1,111 Units purchased by the reporting person for $9.00 per Unit. Each Unit consists of (a) one share of common stock, (b) one Series A Warrant to purchase one share of common stock, and (c) one Series B Warrant to purchase one share of common stock.